Šta je NIPT?
December 16, 2025
Šta je Ekome?
December 16, 2025Šta je NIPT?
December 16, 2025Šta je Ekome?
December 16, 2025
Šta je NIPT?
Šta je NIPT test?
NIPT (neinvazivni prenatalni test) je neinvazivni prenatalni skrining test koji analizira fetalnu DNK bez ćelija (cfDNK) koja cirkuliše u krvi buduće majke kako bi pružila informacije o hromozomskom zdravlju bebe. NIPT je posebno poželjan zbog svoje visoke preciznosti u otkrivanju abnormalnosti broja hromozoma kao što su trizomija 21 (Daunov sindrom), trizomija 18 (Edvardsov sindrom) i trizomija 13 (Patauov sindrom). Ovaj test može da se uradi od 10. nedelje trudnoće nadalje i zahteva samo jednu epruvetu krvi, što ne predstavlja rizik ni za majku ni za bebu.
RapidNIPT je brend usluga NIPT koji nudi Genoks centar za procenu genetskih bolesti. Svi procesi RapidNIPT testa se sprovode kroz potpuno automatizovane sisteme napredne tehnologije u Genoksovim laboratorijama u Ankari. Razvijen korišćenjem savremenih sistema genetske analize usvojenih širom sveta, RapidNIPT pruža bezbedno, sveobuhvatno i naučno utemeljeno iskustvo prenatalnog skrininga. Uz RapidNIPT, porodice mogu da donose bolje informisane odluke tokom trudnoće i steknu rani uvid u potencijalne rizike.
Šta je RapidNIPT?
RapidNIPT is a dedicated NIPT test brand offered by the Genoks Genetic Diseases Assessment Center. All analyses are performed using high-technology systems within a fully automated laboratory infrastructure in Ankara. The process is conducted in accordance with high sensitivity and reliability standards, using methods that minimize human intervention.
RapidNIPT makes the genetic evaluation process patient-focused, fast, and practical. Test results are assessed by experienced medical genetics specialists and are presented to families together with professional genetic counseling.
How Is the RapidNIPT Test Performed?
The RapidNIPT test can be applied from the 10th week of pregnancy onward. The procedure is quite simple:
- A single tube of blood is collected from the expectant mother’s arm, just like a routine blood test.
- cfDNA (cell-free DNA) present in the blood sample is analyzed. cfDNA is genetic material that passes from the placenta into the mother’s bloodstream during pregnancy and provides information about the fetus.
- cfDNA is examined using advanced molecular analysis techniques.
Through this approach, fetal genetic data can be evaluated and a risk analysis for chromosomal abnormalities can be performed.
Down Syndrome and NIPT
The NIPT test is a reliable method particularly used in the assessment of common chromosomal abnormalities such as Down syndrome (Trisomy 21). Down syndrome results from the presence of an extra copy of chromosome 21 and is one of the most frequently observed chromosomal conditions during pregnancy.
Within the scope of screening for Down syndrome risk, RapidNIPT provides families with valuable information. In addition, evaluations can also be performed for other chromosomal abnormalities such as Trisomy 18 and Trisomy 13.
RapidNIPT and cfDNA Analysis
The focus of the RapidNIPT test is cfDNA found in the mother’s blood. cfDNA naturally circulates during pregnancy and reflects the genetic structure of the fetus. Thanks to this modern approach, risk assessment is performed without any invasive procedures, ensuring a safe process for both the mother and the baby.
Advantages of RapidNIPT
- Non-invasive method: Only a blood sample is required.
- Early applicability: Can be performed from the 10th week of pregnancy.
- Broad screening scope: Down syndrome and other chromosomal abnormalities can be evaluated.
- Fast results: Risk assessment can be completed within a short time.
- Expert support: Results are interpreted by physician medical genetics specialists.
Frequently Asked Questions
What is the NIPT test and what is it used for?
NIPT (Non-Invasive Prenatal Test) is based on the analysis of cfDNA in the mother’s blood and provides screening information for certain chromosomal abnormalities such as Down syndrome.
From which week of pregnancy can the NIPT test be performed?
It is generally performed from the 10th week of pregnancy. Suitability should be evaluated by a physician based on individual circumstances.
Is NIPT an invasive procedure?
No. It is performed using only a blood sample and is a non-invasive screening method.
Which chromosomal abnormalities does the NIPT test assess?
Primarily Down syndrome (Trisomy 21), as well as common autosomal aneuploidies such as Trisomy 18 and Trisomy 13, del/dup syndromes larger than 7 Mb, sex chromosome aneuploidies, and additionally DiGeorge syndrome in the PLUS package.
How accurate is the NIPT test?
It has high accuracy rates; however, it is a screening test and provides risk assessment rather than a definitive diagnosis. Diagnostic tests may be recommended if necessary.
How long does it take to receive the results?
RapidNIPT results are reported within 3 to 5 business days, while RapidNIPTPlus results are reported within 7 to 10 business days.
In which situations might a result not be obtained?
Low fetal fraction in early gestational weeks, multiple pregnancies, or technical reasons may affect the result. In such cases, a repeat sample may be requested.
Šta je RapidNIPT?
RapidNIPT is Genoks’ NIPT brand. It offers cfDNA-based non-invasive screening, and results are evaluated by medical genetic specialist physicians together with clinical information.
